Hematology/Oncology Testing

Results you can trust

Our team of hematopathologists provides academic-caliber, definitive diagnoses. Inform Diagnostics believes in responsible assay utilization and only orders those tests that are clinically appropriate for accurate diagnosis, giving patients peace of mind, and helping clinicians build sustainable practices.

Test Offerings

Timely, definitive diagnoses for hematology/oncology

Below is a sampling of tests offered by InformDx. For full test details and indications, please contact us.

Morphology

  • Bone marrow comprehensive diagnostic evaluation
  • Bone marrow morphologic evaluation
  • Peripheral blood comprehensive diagnostic evaluation
  • Peripheral blood morphologic evaluation
  • Tissue morphologic evaluation/consultation (such as lymph node or slides prepared elsewhere)

Immunohistochemistry

  • Immunohistochemistry (IHC) fixed tissue
  • Immunohistochemistry (IHC) paraffin blocks

Flow Cytometry (multiparameter)

  • Bone marrow aspirate
  • Peripheral blood
  • Fresh tissue (such as lymph node or other tissue)
  • Fine needle aspirate (FNA)
  • Body fluids, including cerebrospinal fluid (CSF)
  • ZAP-70 for CLL (peripheral blood only)
  • Paroxysmal nocturnal hemoglobinuria (PNH)

Cytogenetic Analysis

  • Bone marrow aspirate karyotype
  • Peripheral blood karyotype

Fluorescence in situ hybridization (FISH)

  • B-cell acute lymphoblastic leukemia panel
  • Acute myeloid leukemia panel
  • B-cell chronic lymphocytic leukemia panel
  • Chronic myeloid leukemia panel
  • Eosinophilia panel
  • Myelodysplastic syndrome panel
  • Plasma cell neoplasm panel
  • B-cell non-Hodgkin lymphoma panel
  • Follicular lymphoma
  • Burkitt lymphoma
  • Mantle cell lymphoma
  • Anaplastic large cell lymphoma
  • Malignant melanoma
  • UroVysion®

Molecular Testing

  • Acute myeloid leukemia prognostic panel
  • Myeloid malignancy mutation panel by next-gen sequencing (send-out test)
  • KIT (D816V)
  • PML/RARA (quantitative)
  • BCR-ABL major p210/minor p190 (quantitative)
  • BCR/ABL kinase domain point mutation (T315I)
  • JAK2 V617F (qualitative)
  • JAK2 Exon 12 (qualitative)
  • MPL W515L/K (cMPL)
  • Calreticulin (CALR)
  • B-cell clonality (gene rearrangement testing)
  • T-cell clonality (gene rearrangement testing)
  • IgVH mutation analysis for CLL/SLL
  • BCL-1 (qualitative)
  • MYD88 L265P
  • BRAF V600E/Ec for hairy cell Leukemia